c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
1
Page:
305-326
Author(s):
Sam Robson, Stella Pelengaris and Michael Khan
Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
1
Page:
327-346
Author(s):
Stephen J. Ralph, Pauline Low, Langfeng Dong, Alfons Lawen and Jiri Neuzil
Inhibition of Cyclin-Dependent Kinases - A Review of the Recent Patent Literature
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
1
Page:
357-367
Author(s):
Andrea D. Basso and Ronald J. Doll
Bortezomib in the Treatment of Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
1
Page:
397-403
Author(s):
Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti
Editorial [Hot Topic: Beyond Chemotherapy: Future Directions in Lymphoma Treatment (Guest Editor: Thomas Decker)]
Journal:
Current Drug Targets
Volume:
7
Page:
1291-1291
Author(s):
Thomas Decker
Radioimmunotherapy of Non-Hodgkins Lymphomas
Journal:
Current Drug Targets
Volume:
7
Page:
1293-1300
Author(s):
Bruce D. Cheson
Immunotoxins in the Treatment of Hematologic Malignancies
Journal:
Current Drug Targets
Volume:
7
Page:
1301-1311
Author(s):
Robert J. Kreitman and Ira Pastan
Genetics, Gene Expression, and Targeted Therapies in Chronic Lymphocytic Leukemia
Journal:
Current Drug Targets
Volume:
7
Page:
1313-1327
Author(s):
Dirk Winkler, Hartmut Dohner and Stephan Stilgenbauer
Targeting the Oncogenic Tyrosine Kinase NPM-ALK in Lymphoma: The Role of Murine Models in Defining Pathogenesis and Treatment Options
Journal:
Current Drug Targets
Volume:
7
Page:
1329-1334
Author(s):
Cornelius Miething, Christian Peschel and Justus Duyster
The Bcl10 / Malt1 Signaling Pathway as a Drug Target in Lymphoma
Journal:
Current Drug Targets
Volume:
7
Page:
1335-1340
Author(s):
P. Jost, C. Peschel and J. Ruland